| Mauchly-Test | Univariate ANOVAb
| Multivariate ANOVAc
|
---|
(vol.%)
|
P
-value
|
F value
|
P
value
|
test power
|
F value
|
P
value
|
test power
|
TSV
| 0.322 | 2.565 |
0.058
| 0.640 | - | - | - |
TVV
| 0.322 | 2.565 |
0.058
| 0.640 | - | - | - |
TLT
a
| 0.000 | 44.605 | 0.000 | 1.000 | 51.592 |
0.000
| 1.000 |
SLT
a
| 0.000 | 43.573 | 0.000 | 1.000 | 19.556 |
0.001
| 1.000 |
VLT
a
| 0.005 | 22.980 | 0.000 | 1.000 | 6.699 |
0.013
| 0.884 |
TAT
a
| 0.000 | 44.655 | 0.000 | 1.000 | 52.762 |
0.000
| 1.000 |
SAST
a
| 0.000 | 44.721 | 0.000 | 1.000 | 57.109 |
0.000
| 1.000 |
VAT
a
| 0.000 | 23.718 | 0.000 | 1.000 | 8.598 |
0.007
| 0.950 |
-
amean differences are significant; b‘Greenhouse-Geisser’ correction procedure was used; cPillai-Spur, Wilks-Lambda, Hotelling-Spur and ‘biggest characteristical root of Roy’. ANOVA, analysis of variance; SAST, somatic adipose soft tissue; SLT, somatic lean tissue; TAT, total adipose tissue; TLT, total lean tissue; TSV, total somatic volume; TVV, total visceral volume; VAT, visceral adipose tissue; VLT, visceral lean tissue.
- Bold numbers mark the prefered P-value of the prevered ANOVA regarding sphericity assumption proven by Mauchly-Test.